Related Experiment Video
Updated: Dec 7, 2025

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression
Christina Jessen1,2, Julia K C Kreß1,2, Apoorva Baluapuri3
1Department of Physiological Chemistry, University of Würzburg, Würzburg, Germany.
Abstract:
The transcription factor NRF2 is the major mediator of oxidative stress responses and is closely connected to therapy resistance in tumors harboring activating mutations in the NRF2 pathway. In melanoma, such mutations are rare, and it is unclear to what extent melanomas rely on NRF2. Here we show that NRF2 suppresses the activity of the melanocyte lineage marker MITF in melanoma, thereby reducing the expression of pigmentation markers. Intriguingly, we furthermore identified NRF2 as key regulator of immune-modulating genes, linking oxidative stress with the induction of cyclooxygenase 2 (COX2) in an ATF4-dependent manner. COX2 is critical for the secretion of prostaglandin E2 and was strongly induced by H2O2 or TNFα only in presence of NRF2. Induction of MITF and depletion of COX2 and PGE2 were also observed in NRF2-deleted melanoma cells in vivo. Furthermore, genes corresponding to the innate immune response such as RSAD2 and IFIH1 were strongly elevated in absence of NRF2 and coincided with immune evasion parameters in human melanoma datasets. Even in vitro, NRF2 activation or prostaglandin E2 supplementation blunted the induction of the innate immune response in melanoma cells. Transcriptome analyses from lung adenocarcinomas indicate that the observed link between NRF2 and the innate immune response is not restricted to melanoma.
Insights
The transcription factor NRF2 suppresses melanoma cell pigmentation and regulates immune responses by controlling COX2 and prostaglandin E2. Its absence boosts innate immune genes, potentially impacting immune evasion in cancers.
Area of Science:
- Molecular Biology
- Cancer Research
- Immunology
Background:
- Nuclear factor erythroid 2-related factor 2 (NRF2) is a key regulator of oxidative stress responses.
- NRF2's role in melanoma, where NRF2 pathway mutations are rare, is not well understood.
- Understanding NRF2's function is crucial for developing targeted cancer therapies.
Purpose of the Study:
- To investigate the role of NRF2 in melanoma, focusing on its impact on pigmentation and immune modulation.
- To explore the link between oxidative stress, NRF2, and the induction of specific immune-related genes.
- To determine if the NRF2-immune response connection extends to other cancer types.
Main Methods:
- Investigated NRF2's effect on MITF (melanocyte differentiation marker) and pigmentation genes in melanoma cells.
- Assessed NRF2's role in regulating immune-modulating genes, including cyclooxygenase 2 (COX2) and prostaglandin E2 (PGE2) production.
- Utilized NRF2-deleted melanoma cells in vivo and in vitro, alongside transcriptome analysis of human melanoma and lung adenocarcinoma datasets.
Main Results:
- NRF2 suppresses MITF activity, reducing melanoma pigmentation.
- NRF2 is essential for inducing COX2 and PGE2 secretion under oxidative stress (H2O2, TNFα).
- Absence of NRF2 leads to elevated innate immune response genes (e.g., RSAD2, IFIH1) and correlates with immune evasion in human melanoma.
Conclusions:
- NRF2 plays a dual role in melanoma by suppressing pigmentation and regulating immune responses via COX2/PGE2.
- NRF2 deficiency enhances innate immune gene expression, suggesting a link to immune evasion.
- The NRF2-innate immune response axis is conserved in lung adenocarcinomas, indicating broader implications in cancer.
Related Concept Videos
Master Transcription Regulators
MAPK Signaling Cascades
Abnormal Proliferation
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Co-activators and Co-repressors

